Finance

Lists
HYPE3:BVMF
Hypera SA
R$21.17
0.00%
(0.00) 1D
Aug 21, 5:05:49 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for HYPE3...
Open
R$20.83
High
R$21.41
Low
R$20.47
Mkt. cap
14.90B
Avg. vol.
3.03M
Volume
3.36M
Dividend
4.96%
Quarterly dividend
R$0.26
Ex-dividend date
Feb 9, 2026
P/E ratio
7.97
52-wk high
R$26.53
52-wk low
R$19.64
EPS
R$2.66
Shares outstanding
704.01M
No. of employees
11K
Open
R$20.83
High
R$21.41
Low
R$20.47
Mkt. cap
14.90B
Avg. vol.
3.03M
Volume
3.36M
Dividend
4.96%
Quarterly dividend
R$0.26
Ex-dividend date
Feb 9, 2026
P/E ratio
7.97
52-wk high
R$26.53
52-wk low
R$19.64
EPS
R$2.66
Shares outstanding
704.01M
No. of employees
11K
Profile
Hypera Pharma is a Brazilian multinational pharmaceutical company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
About Hypera SA
CEO-
Employees10.6K
Founded2001
HeadquartersItaim Bibi, State of São Paulo, Brazil
SectorPharmaceutical industry
Websitehypera.com.br
Last report
Aug 7, 2026
Fiscal period
Q2 2026
EPS / Est. (BRL)
R$0.70 / R$0.70
-0.54%miss
Revenue / Est. (BRL)
2.34B / 2.33B
+0.28%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.23B
2.24B
2.02B
2.34B
Cost of goods sold
865.21M
858.94M
807.22M
892.99M
Cost of revenue
865.21M
858.94M
807.22M
892.99M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
687.46M
728.46M
703.28M
780.69M
Operating expense
688.45M
728.74M
701.06M
773.84M
Total operating expenses
1.55B
1.59B
1.51B
1.67B
Operating income
673.59M
649.38M
509.50M
669.87M
Other non operating income
-14.67M
-27.28M
-8.73M
-30.17M
EBT including unusual items
448.11M
439.21M
276.14M
492.29M
EBT excluding unusual items
452.42M
438.30M
279.75M
488.66M
Income tax expense
-5.77M
-10.46M
-69.54M
2.28M
Effective tax rate
-1.29%
-2.38%
-25.18%
0.46%
Other operating expenses
987.00K
283.00K
-2.21M
-6.84M
Net income
457.64M
450.99M
347.38M
490.24M
Net profit margin
20.55%
20.16%
17.22%
20.98%
Earnings per share
0.72
0.71
0.55
0.70
Interest and investment income
69.23M
68.87M
64.66M
63.02M
Interest expense
-283.65M
-268.84M
-282.34M
-209.57M
Net interest expenses
-214.42M
-199.97M
-217.68M
-146.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
728.99M
702.34M
562.68M
727.30M
Gain or loss from assets sale
-11.00K
-253.00K
-3.20M
-698.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps